Good Practices in the Clinical Management of Patients with Acute Coronary Syndrome: Retrospective Analysis in a Third-Level Hospital in Mexico

Cardiology Research and Practice
Héctor E Flores-SalinasJorge Ramon Padilla-Gutiérrez

Abstract

This is a retrospective study including male and female patients aged ≥18 years who were diagnosed with ACS. The collected data included demographic characteristics, risk factors, medications, electrocardiograms, surgical procedures, and in-hospital deaths. There are at least 20% more diagnoses of ST-segment elevation myocardial infarction in this hospital compared to the latest national reports in Mexico. The most common risk factors were type 2 diabetes mellitus, hypertension, smoking, and dyslipidaemia. Diabetic patients with a clinical history of percutaneous coronary intervention had a higher risk of non-ST-segment elevation myocardial infarction than nondiabetics (OR: 2.34; p=0.013), also smoking patients with previous heart surgery than nonsmokers (OR: 7.73; p=0.0007). The average in-hospital mortality was 3.6% for ACS. There is a higher percentage of coronary interventionism and improvement in pharmacological treatment, which is reflected in lower mortality. The substantial burden of T2DM could be related to a higher number of cases of STEMI. Diabetics with precedent percutaneous coronary intervention and smokers with previous heart surgery have an increased risk of subsequent infarction.

References

Jan 3, 2015·The American Journal of Medicine·Sami M A AlnasserUNKNOWN GRACE Investigators
Aug 19, 2015·Journal of Basic and Clinical Physiology and Pharmacology·Chandrasekhar DilipDanisha Pattani
Jun 4, 2016·Archivos de cardiología de México·Carlos Martinez-SanchezUNKNOWN RENASICA III Investigators
May 11, 2018·Salud pública de México·Rosalba Rojas-MartínezTonatiuh Barrientos-Gutiérrez

❮ Previous
Next ❯

Software Mentioned

RENASICA

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.